Evidence map›Paper›PMID 26268855›Full record

ArticleThe Journal of infectious diseases2016

Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy.

Lois J Conley, Timothy J Bush, Teresa M Darragh, Joel M Palefsky, Elizabeth R Unger, Pragna Patel, Martin Steinau, E Milu Kojic, Harold Martin, E Turner Overton and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Observational
  2. Article
  3. HIV & Hepatitis in the Americas 28-30 April 2016, Mexico City, Mexico.Journal of the International AIDS Society · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Lois J ConleyDivision of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention.
Timothy J BushDivision of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention.
Teresa M DarraghDivision of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia University of California-San Francisco.
Joel M PalefskyDivision of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia University of California-San Francisco.
Elizabeth R UngerDivision of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia University of California-San Francisco.
Pragna PatelDivision of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention.
Martin SteinauDivision of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia University of California-San Francisco.
E Milu KojicMiriam Hospital, Providence, Rhode Island.
Harold MartinPark-Nicollet Clinic, Minneapolis, Minnesota.
E Turner OvertonUniversity of Alabama School of Medicine, Birmingham.
Susan Cu-UvinMiriam Hospital, Providence, Rhode Island.
John HammerDenver Infectious Disease Consultants, Colorado.
Keith HenryHennepin County Medical Center, Minneapolis, Minnesota.
Kathleen WoodCerner, Vienna, Virginia.
John T BrooksDivision of HIV/AIDS Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention.
SUN Study Group
National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention · USCenters for Disease Control and Prevention · USNational Center for Emerging and Zoonotic Infectious Diseases · USProvidence College · USCerner (United States) · USHennepin County Medical Center · USInfectious Disease Consultants · USPark Nicollet Clinic · USUniversity of Alabama at Birmingham · US

Funding

Intramural CDC HHS CC999999PHS HHS 200-2002-00610PHS HHS 200-2002-00611PHS HHS 200-2002-00612PHS HHS 200-2002-00613PHS HHS 200-2007-23634PHS HHS 200-2007-23635PHS HHS 200-2007-23636PHS HHS 200-2007-3633
6 · The paper itself

Abstract

backgroundAnal cancer rates are higher for human immunodeficiency virus (HIV)-infected adults than for uninfected adults. Limited published data exist characterizing the incidence of precursor lesions detected by anal cytology.

methodsThe Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy was a prospective cohort of 700 HIV-infected participants in 4 US cities. At baseline and annually thereafter, each participant completed a behavioral questionnaire, and healthcare professionals collected anorectal swabs for cytologic examination and human papillomavirus (HPV) detection and genotyping.

resultsAmong 243 participants with negative baseline results of anal cytology, 37% developed abnormal cytology findings (incidence rate, 13.9 cases/100 person-years of follow-up; 95% confidence interval [CI], 11.3-16.9) over a median follow-up duration of 2.1 years. Rates among men having sex with men, among women, and among men having sex with women were 17.9 cases/person-years of follow-up (95% CI, 13.9-22.7), 9.4 cases/person-years of follow-up (95% CI, 5.6-14.9), and 8.9 cases/person-years of follow-up (95% CI, 4.8-15.6), respectively. In multivariable analysis, the number of persistent high-risk HPV types (adjusted hazard ratio [aHR], 1.17; 95% CI, 1.01-1.36), persistent high-risk HPV types except 16 or 18 (aHR, 2.46; 95% CI, 1.31-4.60), and persistent types 16 or 18 (aHR, 3.90; 95% CI, 1.78-8.54) remained associated with incident abnormalities.

conclusionsThe incidence of abnormal anal cytology findings was high and more likely to develop among persons with persistent high-risk HPV.

Indexed as

AdultAnal CanalAnti-HIV AgentsFemaleHIV InfectionsHomosexuality, MaleHumansIncidenceMaleMiddle AgedRisk FactorsAnti-HIV Agentsabnormal anal cytologyHIVHPVincidencepersistence

Identifiers

PMID26268855
PMCPMC6103209
OpenAlexW2244385087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.